Disease X Act of 2023

Bill 118 s 2093, also known as the Disease X Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the potential threat of unknown or emerging infectious diseases, often referred to as "Disease X." The bill seeks to establish a comprehensive framework for detecting, monitoring, and responding to such diseases in order to protect public health and national security.

Key provisions of the Disease X Act of 2023 include the creation of a task force comprised of experts in infectious diseases, public health, and emergency response to develop strategies for early detection and containment of Disease X outbreaks. The bill also calls for increased funding for research and development of vaccines, treatments, and diagnostic tools for unknown or emerging diseases.

Additionally, the legislation emphasizes the importance of international cooperation and information sharing in order to effectively combat Disease X on a global scale. It also mandates regular reporting to Congress on the status of Disease X preparedness and response efforts. Overall, the Disease X Act of 2023 aims to strengthen the nation's ability to respond to the threat of unknown or emerging infectious diseases and to ensure that the US is better prepared to protect the health and safety of its citizens in the face of future outbreaks.